Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
Jon Salmanton‐García(University Hospital Cologne), Summiya Nizamuddin(Shaukat Khanum Memorial Cancer Hospital and Research Center), Nicola Fracchiolla(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Francesco Marchesi(Istituti di Ricovero e Cura a Carattere Scientifico), Tatjana Adžić‐Vukičević, Klára Piukovics(University of Szeged), Jorge Labrador(Hospital Universitario de Burgos), Ditte Stampe Hersby(Copenhagen University Hospital), Sonia Martín‐Pérez(Hospital Nuestra Señora de Alarcos), María Gomes da Silva(Instituto Português de Oncologia Francisco Gentil), Shaimaa El‐Ashwah(Mansoura University), Iker Falces‐Romero(Hospital Universitario La Paz), Moraima Jiménez(Vall d'Hebron Hospital Universitari), Chiara Cattaneo(Humanitas University), Giovanni Paolo Maria Zambrotta(Azienda Ospedaliera San Gerardo), Ildefonso Espigado(Instituto de Biomedicina de Sevilla), Francesca Farina(University of Palermo), Ziad Emarah(Mansoura University), Tommaso Francesco Aiello(Hospital Clínic de Barcelona), Barbora Weinbergerová(University Hospital Brno), Stefanie K. Gräfe(Universität Hamburg), Julio Dávila(Universidad de Salamanca), Mariarita Sciumé(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Güldane Cengiz Seval(Turkish Society of Hematology), Luisa Verga(Azienda Ospedaliera San Gerardo), Caterina Buquicchio, Stef Meers(Hasselt University), Milena Kohn(Inserm), Ola Blennow(Karolinska University Hospital), Caroline Besson(Bicêtre Hospital), Martin Schönlein(Universität Hamburg), Federico Itri(Ospedale San Luigi Gonzaga), Carlo Tascini(Ospedale D. Cotugno), Emanuele Ammatuna(University Medical Center Groningen), Raquel Nunes Rodrigues(Instituto Português de Oncologia Francisco Gentil), Alberto López‐García(Hospital Universitario Fundación Jiménez Díaz), Valentina Bonuomo(University of Verona), Raúl Córdoba(Hospital Universitario Fundación Jiménez Díaz), Yavuz M. Bilgin(Admiraal De Ruyter Ziekenhuis), Ozren Jakšić(University of Zagreb), Monia Marchetti(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Carolina García‐Vidal(Hospital Clínic de Barcelona), Andreas Glenthøj(University of Copenhagen), Jaap A. van Doesum(University Medical Center Groningen), Alba Cabirta-Touzón(Vall d'Hebron Hospital Universitari), Павел Зак(University Hospital Hradec Králové), Elena Arellano(Instituto de Biomedicina de Sevilla), Márcio Nucci(Universidade Federal do Rio de Janeiro), Jens Vian Praet(AZ Sint-Jan), Anna Nordlander(Karolinska University Hospital)
Cited by 34
Related Papers
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium
|The Lancet Infectious Diseases|2019|1.7k
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial
|The Lancet|2007|689
Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis
|Clinical Infectious Diseases|2007|632